GBA Presents: RADIO SAVANT-!

stonedinvestor said:
TWO BUYS:

A) DICE Therapeutics, Inc. (DICE)
NasdaqGM - NasdaqGM Real Time Price.
19.65+0.46(+2.40%)


B) Confluent, Inc. (CFLT)
NasdaqGS - NasdaqGS Real Time Price.
23.25-0.55(-2.31%)
At close: September 29 04:00PM EDT
23.44+0.19(+0.82%)
Pre-Market:08:43AM EDT

Crazy story.

Big party lots of folks for Big Pete's 60th. I did not go.
Guy there drank 3 or 4 glasses of red wine. Legs went paralyzed.
I shit you not guy had to be carried from the table, he wet himself, and hidden from his wife for hours until the next morning when he regained his ability to walk. Apparently he's not supposed to drink at all.

Alcohol paralysis<-- have you veer heard of such a thing!
More...





:sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky:
ALL DAY ALL NIGHT RADIO SAVANT-!
:sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky::sneaky:
 
th%3Fid%3DOIP.Z-nPFadkOTEuXjJGkJYjmQHaHa%26pid%3DApi

Cathie Wood Does A "wtf" Double Take On Radio Savant
 
DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher
Oct. 11, 2022 7:44 AM ETDICE Therapeutics, Inc. (DICE)



image_173682323.jpg





  • Top-line results from a phase 1 trial of DICE Therapeutics' (NASDAQ:DICE) DC-806 for psoriasis showed the candidate met its proof-of-concept goal and was biologically active.
  • Shares are up 71%in premarket trading.
  • Data also showed DC-806 waswell tolerated with an excellent safety profile.
  • The placebo-controlled portion enrolled eight psoriasis patients in the high dose group (800 mg BID), 13 patients in the low dose group (200 mg BID), and 11 patients in the placebo group. After four weeks of treatment, the mean percentage reduction in Psoriasis Area and Severity Index from baseline was 43.7% in the high dose group compared to 13.3% in the placebo group.
  • DICE (DICE) now plans to move DC-806, an oral IL-17 antagonist, into a dose-ranging phase 2b clinical trial. The company anticipates submitting an IND application with the US FDA in 1H 2023 and begin phase 2b at that time.
 
vanzandt said:
The Savant has ALWAYS called you the Bio-Guru.
More...


I know but that's a backhand compliment that means I can't do the other stuff-- that's not true I just always have been way interested in biotech. It comes from my mom And when she got sick with cancer. I was always tryng to cure her through stock ideas.

AMERICAN AIRLINES +

BUY DELTA <-----------------
 
stonedinvestor said:
I know but that's a backhand compliment that means I can't do the other stuff-- that's not true I just always have been way interested in biotech. It comes from my mom And when she got sick with cancer. I was always tryng to cure her through stock ideas.

AMERICAN AIRLINES +

BUY DELTA <-----------------
More...
Well, you do come up with some goofy losers in other areas.

I agree on DAL btw. I was gonna write that yesterday, but hesitant to recommend anything on the downswing.
 
Delta Air Lines makes $60M equity investment in Joby Aviation
Oct. 11, 2022 6:33 AM ETDelta Air Lines, Inc. (DAL),JOBY



image_517342292.jpg


Good Spot Van- Big $ investment.
This is really going to happen!
I don't know if I'll ever take one but...

That movie with Bruce Willis when he is the flying taxi guy ...
it's going to be real.

Now self driving cars I don't know if you have been watching they have been pushed to the no go side of things<-- Thank God.

There will be no self driving cars on the road!<-- Something i have always maintained.

BUT- This air taxi stuff.. Now what happens when the first one crashes?


  • Delta Air Lines (NYSE:DAL) has announced a $60M equity investment and multi-year partnership with air mobility company, Joby Aviation (NYSE:JOBY).
  • The partnership will offer sustainable home-to-airport transportation service to Delta (DAL) customers, beginning in NewYork and Los Angeles.
  • The companies will work together to integrate a Joby-operated service into Delta’s (DAL) customer-facing channels, enabling passengers from New York and Los Angeles to reserve a seat for short-range journeys to and from city airports when booking Delta travel.
  • The partnership will be mutually exclusive across the U.S. and U.K. for five years following commercial launch, with the potential to extend that period.
  • The airline has made an upfront equity investment of $60M in Joby (JOBY), with the opportunity to expand the total investment up to $200M as the partners achieve substantive milestones on the development and delivery of the service.
  • Joby Aviation (JOBY) shares gained~3%premarket
 
You must log in or register to reply here.
Back
Top